LIVELIFE: effectiveness of two types of support for low mood
ISRCTN | ISRCTN65803720 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN65803720 |
Secondary identifying numbers | ASRB4082 |
- Submission date
- 13/10/2008
- Registration date
- 20/11/2008
- Last edited
- 05/04/2013
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Paul Farrand
Scientific
Scientific
School of Psychology
University of Exeter
Room 235
Washington Singer Laboratories
Perry Road
Exeter
EX4 4QG
United Kingdom
Phone | +44 (0)1392 262497 |
---|---|
P.A.Farrand@exeter.ac.uk |
Study information
Study design | Single centre, randomised, phase III, controlled trial with single blinding on the study, research and analysis teams |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Hospital |
Study type | Treatment |
Participant information sheet | Patient information material found at: https://www.onlineassessment.org.uk/lowmoodresearch/index.pl?p=1 |
Scientific title | Effectiveness of two types of support for low mood: a randomised controlled trial and economic analysis |
Study acronym | LIVELIFE |
Study objectives | Compared to the treatment as usual (TAU) by general practitioner (GP) and continued monitoring control group alone, patients receiving NHS Direct telephone support for free to use web-based cognitive behavioural therapy (CBT) self help (Living Life to the Full) will have: 1. Improved mood measured on the Beck Depression Inventory (BDI-II) 2. Improved symptoms and social functioning measured on the 9-item Patient Health Questionnaire (PHQ-9) (depression), 7-item Generalised Anxiety Disorder (GAD-7) (anxiety), and Work And Social Adjustment Scale (WASAS) for social functioning questionnaires 3. Lower health care costs (EQ-5D and Client Services Receipt Interview [CSRI]) 4. Improved mental health literacy 5. Improved acceptability |
Ethics approval(s) | Devon and Torbay Research Ethics Committee gave approval on the 5th March 2008 (ref: 08/H0202/31) |
Health condition(s) or problem(s) studied | Mild to moderate depression, with or without anxiety |
Intervention | Status of trial amended to 'stopped' as of 05/04/2013 due to notification of lack of resources. Intervention: Up to 60 minutes of telephone support for a free to use cognitive behavioural self help web site called Living Life to the Full with treatment as usual from General Practitioner. Control: Continued monitoring and treatment as usual from General Practioner. Duration of treatment is up to 60 minutes of telephone support. Duration of follow up for both arms is dictated by time taken to complete the follow up questionnaires which would be about 45 minutes in total over all follow-up sessions. |
Intervention type | Other |
Primary outcome measure | Beck Depression Inventory II at 4 months follow up. |
Secondary outcome measures | 1. Beck Depression Inventory II at 8 weeks, 4 months and 1 year 2. PHQ-9 depression measure at 8 weeks, 4 months and 1 year 3. GAD-7 anxiety measure at 8 weeks, 4 months and 1 year 4. Work And Social Adjustment Scale (WASAS) questionnaire at 8 weeks, 4 months and 1 year 5. Modified (shortened) EQ5D at 4 months and 1 year 6. Modified (shortened) version of the Client Service Receipt Inventory (CSRI) at 4 months and 1 year 7. Single item satisfaction scale at 8 weeks, 4 months and 1 year 8. Four items assessing mental health literacy at 8 weeks, 4 months and 1 year |
Overall study start date | 20/10/2008 |
Completion date | 28/02/2011 |
Reason abandoned (if study stopped) | Lack of staff/facilities/resources |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Both |
Target number of participants | 184 |
Key inclusion criteria | 1. Aged 16 and above, either sex 2. Currently experiencing mild to moderately severe levels of depression - or depression and anxiety as defined by a score of 5 - 19 on the Patient Health Questionnaire 9 (PHQ-9) |
Key exclusion criteria | 1. Aged under 16 years 2. Do not wish to adopt a self-help format 3. Cannot read/understand the written and audio content 4. Do not have a telephone and computer 5. Do not have access to broadband 6. Have active suicidal intent (defined as a score of 2 or more on the BDI-II suicide item) 7. Have more severe depression (a score greater than 19 on the PHQ) 8. An alcohol intake above 31 and 22 units for men and women respectively 9. People with drug dependency defined as using street drugs every day 10. A history of bipolar disorder 11. Psychosis and depression 12. Currently or have in the last 6 months been referred for supported self-help 13. Those who have started or changed antidepressant type in the last month |
Date of first enrolment | 20/10/2008 |
Date of final enrolment | 28/02/2011 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
School of Psychology
Exeter
EX4 4QG
United Kingdom
EX4 4QG
United Kingdom
Sponsor information
University of Exeter (UK)
University/education
University/education
Washington Singer Laboratories
Perry Road
Exeter
EX4 4QG
England
United Kingdom
Website | http://www.exeter.ac.uk/ |
---|---|
https://ror.org/03yghzc09 |
Funders
Funder type
Government
NHS Direct (UK) - competitive funding (ref: ASRB4082)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |